OnKure Therapeutics, Inc.
Q3 2025 13F Holders
Symbol
OKUR
CUSIP
68277Q105
Type
Equity
Class
COM CL A
Num filings
43
Total reported value, excl. options
$28.1 M
Compare 2025 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type